agilon health (NYSE:AGL) Price Target Raised to $3.00

agilon health (NYSE:AGL) had its price target lifted by Stifel Nicolaus from $2.00 to $3.00 in a research note published on Wednesday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the stock.

A number of other equities analysts have also recently weighed in on the stock. Sanford C. Bernstein raised their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and increased their price target for the company from $1.75 to $2.25 in a report on Friday, January 10th. TD Cowen dropped their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Macquarie assumed coverage on agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Finally, Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Wednesday. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $3.95.

agilon health Price Performance

Shares of AGL stock opened at $3.12 on Wednesday. The firm has a fifty day simple moving average of $2.96 and a 200-day simple moving average of $3.03. The company has a market capitalization of $1.29 billion, a PE ratio of -3.32 and a beta of 0.66. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Insider Activity

In related news, Director Karen Mcloughlin acquired 25,000 shares of agilon health stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John William Wulf acquired 45,000 shares of the stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the purchase, the director now owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders acquired 77,500 shares of company stock valued at $169,600. Company insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in shares of agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after purchasing an additional 272,787 shares during the period. Capital International Investors grew its holdings in agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after buying an additional 9,346,295 shares in the last quarter. State Street Corp increased its position in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after acquiring an additional 215,733 shares during the period. Millennium Management LLC raised its stake in agilon health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after acquiring an additional 4,706,357 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in agilon health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock worth $13,168,000 after acquiring an additional 35,207 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.